- Home
- EVO vs JFR Comparison
EVO vs JFR Comparison
Compare EVO & JFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVO
- JFR
- Stock Information
- Founded
- EVO 1993
- JFR 2004
- Country
- EVO Germany
- JFR United States
- Employees
- EVO N/A
- JFR N/A
- Industry
- EVO Biotechnology: Pharmaceutical Preparations
- JFR Trusts Except Educational Religious and Charitable
- Sector
- EVO Health Care
- JFR Finance
- Exchange
- EVO Nasdaq
- JFR Nasdaq
- Market Cap
- EVO 1.1B
- JFR 1.2B
- IPO Year
- EVO 2021
- JFR N/A
- Fundamental
- Price
- EVO $5.44
- JFR $8.91
- Analyst Decision
- EVO Buy
- JFR
- Analyst Count
- EVO 2
- JFR 0
- Target Price
- EVO $5.90
- JFR N/A
- AVG Volume (30 Days)
- EVO 362.8K
- JFR 621.7K
- Earning Date
- EVO 11-06-2024
- JFR 01-01-0001
- Dividend Yield
- EVO N/A
- JFR 11.31%
- EPS Growth
- EVO N/A
- JFR N/A
- EPS
- EVO N/A
- JFR N/A
- Revenue
- EVO $866,665,179.00
- JFR N/A
- Revenue This Year
- EVO $4.56
- JFR N/A
- Revenue Next Year
- EVO $13.44
- JFR N/A
- P/E Ratio
- EVO N/A
- JFR N/A
- Revenue Growth
- EVO N/A
- JFR N/A
- 52 Week Low
- EVO $2.85
- JFR $7.61
- 52 Week High
- EVO $12.00
- JFR $8.82
- Technical
- Relative Strength Index (RSI)
- EVO 69.82
- JFR 52.00
- Support Level
- EVO $4.34
- JFR $8.95
- Resistance Level
- EVO $4.95
- JFR $8.89
- Average True Range (ATR)
- EVO 0.21
- JFR 0.08
- MACD
- EVO 0.12
- JFR 0.01
- Stochastic Oscillator
- EVO 89.72
- JFR 66.77
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
About JFR Nuveen Floating Rate Income Fund
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income, consistent with the preservation of capital. It invests in adjustable-rate U.S. dollar-denominated secured Senior Loans.